ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0563

Urinary Neutrophil Gelatinase-associated Lipocalin (NGAL) as a Mediator of the Association Between Particulate Matter Exposure and Disease Activity in Systemic Lupus Erythematosus

Ji-Hyoun Kang1, Hyemin Jeong2, Sung-Eun Choi2, Dong-Jin Park2, Han Joo Baek3, Hyo-Jin Choi4, Jae Hyun Jung5 and Shin-Seok Lee2, 1Chonnam National University Hospital, Gwangju, South Korea, 2Chonnam National University Medical School & Hospital, Gwangju, South Korea, 3Gil Medical Center, Gachon University College of Medicine, Inchon, South Korea, 4Gil Medical Center, Gachon University College of Medicine, Incheon, South Korea, 5Korea University Ansan Hospital, Ansan-si, South Korea

Meeting: ACR Convergence 2023

Keywords: Systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 12, 2023

Title: (0543–0581) SLE – Diagnosis, Manifestations, & Outcomes Poster I

Session Type: Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Neutrophil gelatinase-associated lipocalin (NGAL) is an acute-phase glycoprotein increased by inflammatory stimuli, oxidative stress, and tissue injury. Although NGAL is associated with global and renal disease activity in systemic lupus erythematosus (SLE), it is not known whether particulate matter (PM) affects NGAL levels and lupus activity in these patients. Thus, we investigated the mediating role of NGAL in the association between PM10 and PM2.5 exposure and lupus activity in a prospective, longitudinal cohort.

Methods: The study enrolled 386 patients from three metropolitan regions in Korea. The daily average PM10 and PM2.5 concentrations were measured using portable air quality monitors and based on data from the National Ambient Air Monitoring System. Urinary NGAL (uNGAL) was measured at the time of enrollment and at 12 months, and disease activity was evaluated using the SLE Disease Activity Index 2000 (SLEDAI-2K) every 3 months for 1 year. Mixed Cox proportional hazard regression was performed to evaluate the associations of PM10 and PM2.5 with uNGAL and SLE disease activity.

Results: Changes in PM10 and PM2.5 were associated with changes in uNGAL (β = 1.038, 95% confidence interval [CI]: 1.017–1.059, p < 0.001; β = 1.030, 95% CI: 1.001–1.045, p = 0.013, respectively), and with changes of SLEDAI-2K scores of > 8 over 1 year in SLE patients (β = 0.097, 95% CI: 0.048–0.146, p < 0.001; β = 0.100, 95% CI: 0.054–0.146, p < 0.001, respectively). In addition, changes in uNGAL were significantly associated with changes in SLEDAI-2K scores of > 8 (β = 1.000, 95% CI: 1.000–1.002, p = 0.043).

Conclusion: The association between PM exposure and SLE disease activity may be partially explained by uNGAL levels.


Disclosures: J. Kang: None; H. Jeong: None; S. Choi: None; D. Park: None; H. Baek: None; H. Choi: None; J. Jung: None; S. Lee: None.

To cite this abstract in AMA style:

Kang J, Jeong H, Choi S, Park D, Baek H, Choi H, Jung J, Lee S. Urinary Neutrophil Gelatinase-associated Lipocalin (NGAL) as a Mediator of the Association Between Particulate Matter Exposure and Disease Activity in Systemic Lupus Erythematosus [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/urinary-neutrophil-gelatinase-associated-lipocalin-ngal-as-a-mediator-of-the-association-between-particulate-matter-exposure-and-disease-activity-in-systemic-lupus-erythematosus/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/urinary-neutrophil-gelatinase-associated-lipocalin-ngal-as-a-mediator-of-the-association-between-particulate-matter-exposure-and-disease-activity-in-systemic-lupus-erythematosus/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology